How to Buy Zevra Therapeutics Stock
Zevra Therapeutics Inc
Zevra Therapeutics, Inc. , founded in 2006 and based in Celebration, Florida, is a biopharmaceutical company dedicated to discovering and developing innovative treatments for rare diseases.
Zevra Therapeutics stock last closed at $12.65, up 0.8% from the previous day, and has increased 38.63% in one year. It has overperformed other stocks in the Biotechnology industry by 1.1 percentage points. Zevra Therapeutics stock is currently +76.68% from its 52-week low of $7.16, and -11.35% from its 52-week high of $14.27.
At the moment, there are 59.12M ZVRA shares outstanding. The market capitalization of ZVRA is $747.81M. In the past 24 hours, 1.26M ZVRA shares were traded.
How to Buy Zevra Therapeutics Stock
Wondering how to invest in Zevra Therapeutics stock? Here's how.
- Choose where to buy Zevra Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Zevra Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Choose your payment method and add your info.
- Analyze Zevra Therapeutics stock: The Zevra Therapeutics ticker symbol is ZVRA. Is Zevra Therapeutics stock a good investment? Should you buy shares of ZVRA? How do ZVRA's underlying business fundamentals look? Do top analysts think Zevra Therapeutics is a good buy? Why has ZVRA's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ZVRA is a good stock to buy).
- Place your ZVRA trade: Decide if you will purchase ZVRA shares at the current market price or use a limit order to purchase ZVRA stock at a given price.
- Monitor your investment in ZVRA: Create a watchlist to key updates about your investment in Zevra Therapeutics stock.
Step 1: Choose where to buy Zevra Therapeutics stock
You need an online brokerage account in order to access the NASDAQ market and buy ZVRA shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal info so you are able to invest in ZVRA stock today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new brokerage account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've finished signing up on stock apps to use, your next step is to transfer the money for your investment:
Watch the video below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Zevra Therapeutics stock
Once you have identified the best place to buy Zevra Therapeutics stock, it's important to evaluate their stock before you invest, so you truly understand the risk as well as the upside.
Zevra Therapeutics stock quick numbers
ZVRA Fundamentals
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on ZVRA's stock page.
Is ZVRA stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ZVRA's fair value.
Using relative valuations methods:
- ZVRA may be undervalued based on its P/E ratio of 6.17x, relative to Biotechnology industry P/E ratio of 16.03x
- ZVRA may be undervalued based on its P/B ratio of 3.63x, relative to Biotechnology industry P/B ratio of 4.86x
- ZVRA could be undervalued based on its PEG ratio of 0.82x
You can access more valuation analysis on ZVRA's stock here.
ZVRA Financials at a glance
Positive Health Checks:
- ZVRA profit margin has gone up from -226.6% to 101.6% in the past year.
- ZVRA has a low debt to equity ratio of 0.35.
- ZVRA earnings of $141.12M is not enough to cover its interest payments.
- ZVRA's operating cash flow of $12.77M allows it to safely service it's debt of $1.15M.
- There are more short-term assets than short-term liabilities on the ZVRA balance sheet.
- There are more short-term assets than long-term liabilities on the ZVRA balance sheet.
Negative Health Checks:
- Total ZVRA debt is higher than 5 years ago, relative to shareholder equity.
Is ZVRA stock a Buy, Hold, or Sell, according to analysts?
Out of 6 sell side analysts who give recommendations on ZVRA, the consensus analyst rating on ZVRA is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent ZVRA Analyst Forecasts
Kristen Kluska, a top 3% analyst from Cantor Fitzgerald maintains ZVRA with a strong buy rating and raises their ZVRA price target from $24.00 to $34.00, on Jun 8, 2026.
Cantor Fitzgerald's Kristen Kluska raised their price target on Zevra Therapeutics (NASDAQ: ZVRA) by 41.7% from $24 to $34 on 2026/06/08. The analyst maintained their Strong Buy rating on the stock.
Kluska attributed their price target hike to Zevra Therapeutics announcing "a new patent to the U.S. FDA for listing in the Orange Book for Miplyffa for Niemann-Pick disease type C."
The analyst explained that the patent expires on 2041/11/19, dictating when generic competitors can legally enter the market.
Kluska added that the patent and its expiry date have a "significantly positive impact" on their discounted cash flow analysis on Zevra Therapeutics.
You can dive deeper into what analysts are saying on the Zevra Therapeutics stock forecast page.
ZVRA Technical Indicators
Is ZVRA Making Money?
Last year, ZVRA revenue was $122.29M. In the past five year, ZVRA's revenue has grown by 39.3% per year. This was faster than the Biotechnology industry average of 32.16%.
Dig into ZVRA's earnings and revenue performance here.
Latest Insiders Trades at ZVRA
In the past 12 months, insiders at ZVRA have sold more shares than they have bought.
Rahsaan Thompson, Chief Legal Compliance of ZVRA, was the latest ZVRA insider to sell. They sold $20,272.20 worth of ZVRA shares on May 11, 2026.
Learn more about who owns ZVRA stock here.
Does ZVRA stock generate passive income?
No, Zevra Therapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your ZVRA trade
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the easiest way to buy. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, place a limit order.
Press the Open Trade button and eToro will execute the order.
If you want more help investing in stocks on eToro, click the helpful video below:
Step 6: Monitor your investment in ZVRA
Now that you own some ZVRA stock, you'll want to keep up with your stock purchase.
Put ZVRA on a watchlist to track the latest developments regarding your ZVRA stock.
ZVRA Feed
How to Buy Stock in Zevra Therapeutics
To summarize, here are the 6 steps to buy Zevra Therapeutics stock:
- Choose where to buy Zevra Therapeutics stock
- Create a brokerage account
- Put funds into your brokerage account
- Analyze Zevra Therapeutics stock
- Place your ZVRA trade
- Monitor your investment in ZVRA
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your investment in Zevra Therapeutics, add ZVRA to your watchlist below.
Other Content You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.